JW Holdings Corporation (096760.KS)
KRW 3045.0
(0.0%)
KRW 3045.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 147.58 Billion KRW | -2.05% |
| 2022 | 150.68 Billion KRW | 2.88% |
| 2021 | 146.47 Billion KRW | -2.8% |
| 2020 | 150.69 Billion KRW | -9.54% |
| 2019 | 166.59 Billion KRW | -1.28% |
| 2018 | 168.74 Billion KRW | 5.0% |
| 2017 | 160.7 Billion KRW | 20.58% |
| 2016 | 133.28 Billion KRW | 20.95% |
| 2015 | 110.19 Billion KRW | 15.37% |
| 2014 | 95.51 Billion KRW | -11.7% |
| 2013 | 108.17 Billion KRW | 1.56% |
| 2012 | 106.51 Billion KRW | -4.46% |
| 2011 | 111.47 Billion KRW | -5.78% |
| 2010 | 118.31 Billion KRW | -8.57% |
| 2009 | 129.41 Billion KRW | 20.22% |
| 2008 | 107.64 Billion KRW | 26.49% |
| 2007 | 85.1 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 154.24 Billion KRW | 4.51% |
| 2024 Q2 | 154.84 Billion KRW | 0.38% |
| 2023 Q4 | 147.58 Billion KRW | -5.19% |
| 2023 Q3 | 155.67 Billion KRW | -3.14% |
| 2023 Q2 | 160.72 Billion KRW | -0.16% |
| 2023 FY | 147.58 Billion KRW | -2.05% |
| 2023 Q1 | 160.98 Billion KRW | 6.83% |
| 2022 Q2 | 154.78 Billion KRW | 1.53% |
| 2022 Q3 | 147.96 Billion KRW | -4.41% |
| 2022 Q4 | 150.68 Billion KRW | 1.84% |
| 2022 Q1 | 152.45 Billion KRW | 4.09% |
| 2022 FY | 150.68 Billion KRW | 2.88% |
| 2021 FY | 146.47 Billion KRW | -2.8% |
| 2021 Q3 | 151.5 Billion KRW | 1.44% |
| 2021 Q2 | 149.35 Billion KRW | 0.88% |
| 2021 Q1 | 148.05 Billion KRW | -1.75% |
| 2021 Q4 | 146.47 Billion KRW | -3.32% |
| 2020 Q4 | 150.69 Billion KRW | -17.6% |
| 2020 Q1 | 189.15 Billion KRW | 13.54% |
| 2020 FY | 150.69 Billion KRW | -9.54% |
| 2020 Q2 | 190.01 Billion KRW | 0.45% |
| 2020 Q3 | 182.87 Billion KRW | -3.76% |
| 2019 Q1 | 172.3 Billion KRW | 2.11% |
| 2019 Q3 | 176.47 Billion KRW | -1.15% |
| 2019 FY | 166.59 Billion KRW | -1.28% |
| 2019 Q2 | 178.52 Billion KRW | 3.61% |
| 2019 Q4 | 166.59 Billion KRW | -5.6% |
| 2018 Q4 | 168.74 Billion KRW | -5.06% |
| 2018 Q3 | 177.74 Billion KRW | 0.92% |
| 2018 Q2 | 176.12 Billion KRW | 9.88% |
| 2018 Q1 | 160.29 Billion KRW | -0.26% |
| 2018 FY | 168.74 Billion KRW | 5.0% |
| 2017 Q2 | 152.14 Billion KRW | 1.81% |
| 2017 Q4 | 160.7 Billion KRW | 3.31% |
| 2017 FY | 160.7 Billion KRW | 20.58% |
| 2017 Q3 | 155.56 Billion KRW | 2.25% |
| 2017 Q1 | 149.43 Billion KRW | 12.12% |
| 2016 Q3 | 109.86 Billion KRW | 2.21% |
| 2016 FY | 133.28 Billion KRW | 20.95% |
| 2016 Q1 | 110.37 Billion KRW | 0.16% |
| 2016 Q4 | 133.28 Billion KRW | 21.31% |
| 2016 Q2 | 107.48 Billion KRW | -2.62% |
| 2015 Q4 | 110.19 Billion KRW | 7.28% |
| 2015 FY | 110.19 Billion KRW | 15.37% |
| 2015 Q3 | 102.71 Billion KRW | 5.72% |
| 2015 Q2 | 97.15 Billion KRW | 2.71% |
| 2015 Q1 | 94.59 Billion KRW | -0.96% |
| 2014 Q4 | 95.51 Billion KRW | -6.45% |
| 2014 Q3 | 102.1 Billion KRW | -2.5% |
| 2014 FY | 95.51 Billion KRW | -11.7% |
| 2014 Q1 | 118.26 Billion KRW | 9.33% |
| 2014 Q2 | 104.72 Billion KRW | -11.46% |
| 2013 Q3 | 98.4 Billion KRW | 0.62% |
| 2013 Q4 | 108.17 Billion KRW | 9.92% |
| 2013 FY | 108.17 Billion KRW | 1.56% |
| 2013 Q1 | 110.46 Billion KRW | 3.71% |
| 2013 Q2 | 97.8 Billion KRW | -11.46% |
| 2012 FY | 106.51 Billion KRW | -4.46% |
| 2012 Q4 | 106.51 Billion KRW | 0.0% |
| 2011 Q3 | - KRW | 0.0% |
| 2011 Q1 | - KRW | 0.0% |
| 2011 Q2 | - KRW | 0.0% |
| 2011 FY | 111.47 Billion KRW | -5.78% |
| 2010 Q3 | - KRW | 0.0% |
| 2010 Q2 | - KRW | 0.0% |
| 2010 Q1 | - KRW | 0.0% |
| 2010 FY | 118.31 Billion KRW | -8.57% |
| 2009 Q3 | - KRW | 0.0% |
| 2009 Q1 | - KRW | 0.0% |
| 2009 FY | 129.41 Billion KRW | 20.22% |
| 2009 Q2 | - KRW | 0.0% |
| 2008 Q1 | - KRW | 0.0% |
| 2008 Q2 | - KRW | 0.0% |
| 2008 FY | 107.64 Billion KRW | 26.49% |
| 2008 Q3 | - KRW | 0.0% |
| 2007 Q3 | 196.28 Million KRW | 0.0% |
| 2007 FY | 85.1 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -234.275% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | -25.233% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | -61.89% |
| HANDOK Inc. | 94.46 Billion KRW | -56.238% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -594.764% |
| Yuhan Corporation | 284.75 Billion KRW | 48.17% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | -26.889% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -807.758% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 48.898% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -355.746% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -139.109% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -657.761% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -387.412% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -205.269% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -234.275% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -372.426% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -319.569% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -206.659% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | -74.407% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 43.546% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -39.116% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -173.703% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -446.669% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -353.962% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | -34.456% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -234.275% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | 21.762% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | 38.898% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -39.116% |
| Yuhan Corporation | 284.75 Billion KRW | 48.17% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | -17.808% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | -138.099% |
| Suheung Co., Ltd. | 259.84 Billion KRW | 43.2% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -39.116% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | -85.407% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -200.333% |
| CKD Bio Corp. | 69.08 Billion KRW | -113.643% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | -40.457% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | -108.763% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | -173.021% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -173.703% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | 24.222% |
| Boryung Corporation | 189.8 Billion KRW | 22.242% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | -159.695% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -139.109% |
| JW Lifescience Corporation | 23.39 Billion KRW | -530.762% |